The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion
The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion
复制标题
DOI：
10.1016/j.fertnstert.2018.01.002
复制
发表时间：
2018-03-01
影响因子：
6.7
通讯作者：
中科院分区：
文献类型：
--
作者：
植入前非整倍体基因检测（PGT-A）作为体外受精（IVF）患者筛查试验的价值尚未确定。一些研究表明，非整倍体检测和选择性单胚胎移植（eSET）后的出生率更高，这表明这种检测有可能降低多胎妊娠的风险，尽管这些研究有重要的局限性。(C)2018年，美国生殖医学会（American Society for Reproductive Medicine）
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations. (C) 2018 by American Society for Reproductive Medicine.